<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03844724</url>
  </required_header>
  <id_info>
    <org_study_id>ZYLOX2014001</org_study_id>
    <nct_id>NCT03844724</nct_id>
  </id_info>
  <brief_title>Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion</brief_title>
  <official_title>Safety and Efficacy of ZENFlow™ Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Iliac, Femoral and Popliteal Artery Stenosis or Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Zylox Medical Device Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Zylox Medical Device Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical study on safety and efficacy of ZENFlow™ drug-eluting PTA balloon dilatation
      catheter in the treatment of iliac, femoral and popliteal artery stenosis or occlusion
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study was to evaluate the safety and efficacy of ZENFlow™ drug-eluting
      PTA balloon dilatation catheter (paclitaxel 3±1 μg/mm2 balloon surface area) in the treatment
      of iliac artery, femoral artery and popliteal stenosis or occlusive lesions compared with
      conventional PTA balloon dilatation catheter.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2015</start_date>
  <completion_date type="Actual">October 22, 2018</completion_date>
  <primary_completion_date type="Actual">March 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Late Lumen Loss at 6 months after operation</measure>
    <time_frame>6 months</time_frame>
    <description>Late Lumen Loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of major adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Related to death of clinical trials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event</measure>
    <time_frame>Preoperative、Intraoperative、up to 1 month、3 months、6 months、9 months、12 months</time_frame>
    <description>Adverse medical events, whether or not related to the medical device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">204</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Iliac Artery Stenosis</condition>
  <condition>Femoral Artery Stenosis</condition>
  <condition>Popliteal Artery Stenosis</condition>
  <condition>Iliac Artery Occlusion</condition>
  <condition>Femoral Artery Occlusion</condition>
  <condition>Popliteal Artery Occlusion</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects using the drug-eluting PTA balloon dilatation catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects using the peripheral balloon dilatation catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ZENFlow™ Drug-eluting PTA Balloon Dilatation Catheter</intervention_name>
    <description>Digital subtraction angiography（DSA）</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peripheral Balloon Dilatation Catheter</intervention_name>
    <description>Digital subtraction angiography（DSA）</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged from 18 to 85 years old, male or female

          -  Subject's target lesions were stenosis and/or occlusion

          -  Subjects were able to understand the purpose of the study, demonstrate full compliance
             with the program and sign informed consent

        Exclusion Criteria:

          -  Pregnant woman or who's pregnancy test is positive

          -  Lactation period woman or woman/man with fertility plan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Changwei Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>February 15, 2019</last_update_submitted>
  <last_update_submitted_qc>February 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peripheral Arterial Disease</keyword>
  <keyword>Drug-eluting PTA Balloon Dilatation Catheter</keyword>
  <keyword>Late Lumen Loss（6 months）</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

